Cooley partner John Dwyer, a go-to lawyer for eBay, will represent Meg Whitman in investor class actions over HP's ill-fated acquisition of British software firm Autonomy.

When a Manhattan federal district court judge denied IBM's motion to enjoin its former M&A chief from joining Dell, IBM filed another one. And when the judge called the tactic "vexatious," IBM asked the Second Circuit for a writ of mandamus. Last Thursday the appellate court said no.

As we concluded in a post last week, no one really knows whether IP litigation is up or down. But one subset of IP litigation seems to be thriving: the wars between drug manufacturers and generics. We've got news to report in a six-year-old battle between Japanese drugmaker Daiichi Sankyo and generic maker Apotex. In an opinion made public Tuesday, a New Jersey district court dismissed with prejudice Apotex's antitrust claims against Daiichi.

Van Sicklen was drastically outnumbered in the courtroom when he argued for confirmation of the Wisconsin insurance commissioner's plan to segregate $60 billion in Ambac insurance policies in an account that will pay policyholders only 25 cents on the dollar in cash. But sometimes, smaller is better.